Expression Profile of EMT-related Genes and miRNAs Involved in Signal Transduction via the Wnt Pathway and Cadherins in Endometrial Cancer

Epithelial-mesenchymal transition (EMT) is a molecular reprogramming that leads to an increased ability to migrate, which can promote invasion and metastasis. EMT can be initiated in response to the activity of signaling pathways such as Wnt as well as miRNAs. The aim of the study was to determine t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current pharmaceutical biotechnology Jg. 22; H. 12; S. 1663
Hauptverfasser: Zmarzły, Nikola, Hermyt, Ewelina, Kruszniewska-Rajs, Celina, Gola, Joanna, Witek, Andrzej, Mazurek, Urszula, Ostenda, Aleksander, Boroń, Dariusz
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Netherlands 01.01.2021
Schlagworte:
ISSN:1873-4316, 1873-4316
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Epithelial-mesenchymal transition (EMT) is a molecular reprogramming that leads to an increased ability to migrate, which can promote invasion and metastasis. EMT can be initiated in response to the activity of signaling pathways such as Wnt as well as miRNAs. The aim of the study was to determine the expression profile of EMT-related genes involved in signal transduction via the Wnt pathway and cadherins, and to assess which miRNAs can participate in the regulation of their expression. The study material consisted of 50 endometrial samples: 40 with diagnosed endometrial cancer and 10 without neoplastic changes. Expression profile of EMT-related genes was assessed with microarrays and validated by RT-qPCR. MicroRNA expression profiling was performed using microarrays. It was also determined which miRNAs may participate in the expression regulation of EMT-related genes. CDH1 overexpression was observed in all three endometrial cancer grades using both mRNA microarrays and RTqPCR. Microarray experiment showed a decrease in CDH2 level regardless of the endometrial cancer grade, however it was only partially validated with RT-qPCR. Low levels of WNT2, WNT4, WNT5A have also been observed. Decreased expression of WNT2 and WNT5A may be caused by miR-331-3p and miR-200b-5p, respectively. The Wnt signaling is disrupted in endometrial cancer, which may be due to miR-331-3p and miR-200b-5p activity. In addition, a change in WNT5A level in endometrial cancer compared to control may indicate that it acts as a suppressor gene and that its low expression is associated with tumor progression.
AbstractList Epithelial-Mesenchymal Transition (EMT) is a molecular reprogramming that leads to an increased ability to migrate, which can promote invasion and metastasis. EMT can be initiated in response to the activity of signaling pathways such as Wnt as well as miRNAs.BACKGROUNDEpithelial-Mesenchymal Transition (EMT) is a molecular reprogramming that leads to an increased ability to migrate, which can promote invasion and metastasis. EMT can be initiated in response to the activity of signaling pathways such as Wnt as well as miRNAs.The aim of the study was to determine the expression profile of EMT-related genes involved in signal transduction via the Wnt pathway and cadherins and to assess which miRNAs can participate in the regulation of their expression.OBJECTIVEThe aim of the study was to determine the expression profile of EMT-related genes involved in signal transduction via the Wnt pathway and cadherins and to assess which miRNAs can participate in the regulation of their expression.The study material consisted of 50 endometrial samples: 40 with diagnosed endometrial cancer and 10 without neoplastic changes. The expression profile of EMT-related genes was assessed with microarrays and validated by RT-qPCR. MicroRNA expression profiling was performed using microarrays. It was also determined which miRNAs may participate in the expression regulation of EMT-related genes.METHODSThe study material consisted of 50 endometrial samples: 40 with diagnosed endometrial cancer and 10 without neoplastic changes. The expression profile of EMT-related genes was assessed with microarrays and validated by RT-qPCR. MicroRNA expression profiling was performed using microarrays. It was also determined which miRNAs may participate in the expression regulation of EMT-related genes.CDH1 overexpression was observed in all three endometrial cancer grades using both mRNA microarrays and RT-qPCR. The microarray experiment showed a decrease in CDH2 level regardless of the endometrial cancer grade, however, it was only partially validated with RT-qPCR. Low levels of WNT2, WNT4, WNT5A have also been observed. Decreased expression of WNT2 and WNT5A may be caused by miR-331-3p and miR-200b-5p, respectively.RESULTSCDH1 overexpression was observed in all three endometrial cancer grades using both mRNA microarrays and RT-qPCR. The microarray experiment showed a decrease in CDH2 level regardless of the endometrial cancer grade, however, it was only partially validated with RT-qPCR. Low levels of WNT2, WNT4, WNT5A have also been observed. Decreased expression of WNT2 and WNT5A may be caused by miR-331-3p and miR-200b-5p, respectively.The Wnt signaling is disrupted in endometrial cancer, which may be due to miR-331- 3p and miR-200b-5p activity. In addition, a change in WNT5A level in endometrial cancer compared to control may indicate that it acts as a suppressor gene and that its low expression is associated with tumor progression.CONCLUSIONThe Wnt signaling is disrupted in endometrial cancer, which may be due to miR-331- 3p and miR-200b-5p activity. In addition, a change in WNT5A level in endometrial cancer compared to control may indicate that it acts as a suppressor gene and that its low expression is associated with tumor progression.
Epithelial-mesenchymal transition (EMT) is a molecular reprogramming that leads to an increased ability to migrate, which can promote invasion and metastasis. EMT can be initiated in response to the activity of signaling pathways such as Wnt as well as miRNAs. The aim of the study was to determine the expression profile of EMT-related genes involved in signal transduction via the Wnt pathway and cadherins, and to assess which miRNAs can participate in the regulation of their expression. The study material consisted of 50 endometrial samples: 40 with diagnosed endometrial cancer and 10 without neoplastic changes. Expression profile of EMT-related genes was assessed with microarrays and validated by RT-qPCR. MicroRNA expression profiling was performed using microarrays. It was also determined which miRNAs may participate in the expression regulation of EMT-related genes. CDH1 overexpression was observed in all three endometrial cancer grades using both mRNA microarrays and RTqPCR. Microarray experiment showed a decrease in CDH2 level regardless of the endometrial cancer grade, however it was only partially validated with RT-qPCR. Low levels of WNT2, WNT4, WNT5A have also been observed. Decreased expression of WNT2 and WNT5A may be caused by miR-331-3p and miR-200b-5p, respectively. The Wnt signaling is disrupted in endometrial cancer, which may be due to miR-331-3p and miR-200b-5p activity. In addition, a change in WNT5A level in endometrial cancer compared to control may indicate that it acts as a suppressor gene and that its low expression is associated with tumor progression.
Author Ostenda, Aleksander
Kruszniewska-Rajs, Celina
Gola, Joanna
Hermyt, Ewelina
Mazurek, Urszula
Witek, Andrzej
Zmarzły, Nikola
Boroń, Dariusz
Author_xml – sequence: 1
  givenname: Nikola
  surname: Zmarzły
  fullname: Zmarzły, Nikola
  organization: Department of Histology, Cytophysiology and Embryology, Faculty of Medicine in Zabrze, University of Technology in Katowice, Zabrze. Poland
– sequence: 2
  givenname: Ewelina
  surname: Hermyt
  fullname: Hermyt, Ewelina
  organization: Department of Gynecology and Obstetrics, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Katowice. Poland
– sequence: 3
  givenname: Celina
  surname: Kruszniewska-Rajs
  fullname: Kruszniewska-Rajs, Celina
  organization: Department of Molecular Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Sosnowiec. Poland
– sequence: 4
  givenname: Joanna
  surname: Gola
  fullname: Gola, Joanna
  organization: Department of Molecular Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Sosnowiec. Poland
– sequence: 5
  givenname: Andrzej
  surname: Witek
  fullname: Witek, Andrzej
  organization: Department of Gynecology and Obstetrics, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Katowice. Poland
– sequence: 6
  givenname: Urszula
  surname: Mazurek
  fullname: Mazurek, Urszula
  organization: Jozef Tyszkiewicz Higher School in Bielsko-Biała, Bielsko-Biała. Poland
– sequence: 7
  givenname: Aleksander
  surname: Ostenda
  fullname: Ostenda, Aleksander
  organization: Faculty of Medicine in Zabrze, University of Technology in Katowice, Zabrze. Poland
– sequence: 8
  givenname: Dariusz
  surname: Boroń
  fullname: Boroń, Dariusz
  organization: Department of Histology, Cytophysiology and Embryology, Faculty of Medicine in Zabrze, University of Technology in Katowice, Zabrze. Poland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33342410$$D View this record in MEDLINE/PubMed
BookMark eNpNkM1OwzAQhC1URH_gFZC5cQl47cRJjlVVSqUCFRRxrNx4Q40Sp9hJoa_AU5NCkTjNSDPfSLt90rGVRUIugF1xiMNrEEnKGTAOUsrWcEiARyljR6QHSSyCUIDs_PNd0vf-jTHOkoSfkK4QIuQhsB75Gn9uHHpvKkvnrspNgbTK6fhuETgsVI2aTtCip8pqWprH-6GnU7utim2bGEufzKtVBV04Zb1usnq_szWK1mukL7amc1WvP9TuBx8pvUZnrN-DY6urEmtnWnqkbIbulBznqvB4dtABeb4ZL0a3wexhMh0NZ8EqklAHMseYRSAF5CLKwjSKMNVCiSTT7XUiS5GxbCWFkAoVzwUHxiKepCsEyDQHPiCXv7sbV7036OtlaXyGRaEsVo1f8jCGSKRxmrTV80O1WZWolxtnSuV2y7__8W8wCHWX
CitedBy_id crossref_primary_10_1007_s12033_023_00876_y
crossref_primary_10_3389_fphys_2022_937988
crossref_primary_10_1007_s10528_022_10278_5
crossref_primary_10_3892_mmr_2023_13037
crossref_primary_10_1080_15384101_2022_2103342
crossref_primary_10_1016_j_adcanc_2023_100111
crossref_primary_10_1016_j_ygeno_2023_110718
crossref_primary_10_3389_fendo_2023_1166948
crossref_primary_10_3389_fgene_2022_828456
crossref_primary_10_3390_cancers13102351
crossref_primary_10_1186_s12958_021_00786_1
crossref_primary_10_3390_cancers15194780
ContentType Journal Article
Copyright Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Copyright_xml – notice: Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
DBID NPM
7X8
DOI 10.2174/1389201021666201218125900
DatabaseName PubMed
MEDLINE - Academic
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-4316
ExternalDocumentID 33342410
Genre Journal Article
GroupedDBID ---
.5.
0R~
29F
36B
4.4
53G
5GY
AAEGP
ABEEF
ABJNI
ABMOS
ACGFS
ACITR
ACIWK
ACPRK
ACZAY
AENEX
AFRAH
AFUQM
AGJNZ
ALMA_UNASSIGNED_HOLDINGS
ANTIV
CS3
DU5
EBS
F5P
GH2
HZ~
IPNFZ
KCGFV
NPM
O9-
P2P
RIG
7X8
AFHZU
AGQPQ
ID FETCH-LOGICAL-b561t-6fe7051631f35c4955e9d3a38cd0883c9e00cb6336aea2f321005289be11cd212
IEDL.DBID 7X8
ISICitedReferencesCount 12
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000684541400011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1873-4316
IngestDate Sun Nov 09 09:44:24 EST 2025
Thu Apr 03 06:57:59 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords endometrial cancer
miRNA
cadherins
WNT
EMT
microarrays
Language English
License Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b561t-6fe7051631f35c4955e9d3a38cd0883c9e00cb6336aea2f321005289be11cd212
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doi.org/10.2174/1389201021666201218125900
PMID 33342410
PQID 2471539798
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2471539798
pubmed_primary_33342410
PublicationCentury 2000
PublicationDate 2021-01-01
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – month: 01
  year: 2021
  text: 2021-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Current pharmaceutical biotechnology
PublicationTitleAlternate Curr Pharm Biotechnol
PublicationYear 2021
SSID ssj0020882
Score 2.3535576
Snippet Epithelial-mesenchymal transition (EMT) is a molecular reprogramming that leads to an increased ability to migrate, which can promote invasion and metastasis....
Epithelial-Mesenchymal Transition (EMT) is a molecular reprogramming that leads to an increased ability to migrate, which can promote invasion and metastasis....
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1663
Title Expression Profile of EMT-related Genes and miRNAs Involved in Signal Transduction via the Wnt Pathway and Cadherins in Endometrial Cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/33342410
https://www.proquest.com/docview/2471539798
Volume 22
WOSCitedRecordID wos000684541400011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwELZoqSouLX3xKKBBQpywSOw8TwihRSDBKirbsreVYztVDjhAlqX7F_qrO-OE7gkJiUsuluVIM575PK-PsT10qUqHMuYRYgNOTLA8S0zC8ygl9B6oxFdV_rpIh8NsPM6LPuDW9mWVTzbRG2rTaIqRHwq0ojElobKj2ztOrFGUXe0pNN6wZYlQhrQ6Hf_PIgiCj_TgylLJqeX7Pdul0mcE4YeUnxOe1xrxu6DBZujpiEHzeaTpPc7px9f-6yr70GNNOO6U4xNbsu4z2y-6YdXzAxgteq_aA9iHYjHGev6F_R386YtkHRQdszc0FQwuR9w3wFgDNLO6BeUM3NQ_hsctnDu0djNcqR1c1b_pdO8MTTejFma1AkSccO2mUCD2fFRzv_1EGd-H2NLGgTPNjfV0IriASnn_lf08HYxOznjP3MBLxGNTnlQ2xdueyLCSscY3WGxzI5XMtEGZSJ3bINBlImWirBIV9REFMT79ShuG2qA3_cbeusbZdQZpbMpMW6EpQiWkzXWkgsqUcSC0jkK7wXafZDDBm0HpDuVs89BOFlLYYGudICe33QiPiZQyQuwSbL5g93e2IqiQxcddtthyhXbBbrN3ejat2_sdr3L4HRaX_wBw696n
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Expression+Profile+of+EMT-related+Genes+and+miRNAs+Involved+in+Signal+Transduction+via+the+Wnt+Pathway+and+Cadherins+in+Endometrial+Cancer&rft.jtitle=Current+pharmaceutical+biotechnology&rft.au=Zmarz%C5%82y%2C+Nikola&rft.au=Hermyt%2C+Ewelina&rft.au=Kruszniewska-Rajs%2C+Celina&rft.au=Gola%2C+Joanna&rft.date=2021-01-01&rft.issn=1873-4316&rft.eissn=1873-4316&rft.volume=22&rft.issue=12&rft.spage=1663&rft_id=info:doi/10.2174%2F1389201021666201218125900&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1873-4316&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1873-4316&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1873-4316&client=summon